These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 675713)

  • 1. Dopamine and noradrenaline levels in the brains of lead and zinc poisoned rats.
    Satija NK; Seth TD; Tandon DS
    Toxicology; 1978 May; 10(1):13-6. PubMed ID: 675713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of brain noradrenaline, dopamine and 5-hydroxytryptamine levels during vanadium poisoning.
    Witkowska D; Brzeziński J
    Pol J Pharmacol Pharm; 1979; 31(4):393-8. PubMed ID: 523342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperactivity and brain catecholamines in lead-exposed developing rats.
    Sauerhoff MW; Michaelson IA
    Science; 1973 Dec; 182(4116):1022-4. PubMed ID: 4795926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of vasopressin and oxytocin on cerebral noradrenaline and dopamine contents and on plasma corticosterone levels].
    Kovács LG; Telegdy G
    Acta Pharm Hung; 1978; 48 Suppl():70-2. PubMed ID: 749535
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional effects on the cerebral concentration of noradrenaline, serotonin and dopamine in suckling rats after a single dose of lindane.
    Rivera S; Sanfeliu C; Suñol C; Rodríguez-Farré E
    Toxicology; 1991; 69(1):43-54. PubMed ID: 1718055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal absorption of thiamine, glucose and sodium in rats after lead and joint lead-zinc treatment.
    Dolezych S
    Acta Physiol Pol; 1988; 39(3):195-201. PubMed ID: 3227869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain.
    Andén N; Grabowska M
    Eur J Pharmacol; 1976 Oct; 39(2):275-82. PubMed ID: 185062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural and neurochemical consequences of neonatal exposure to lead in rats.
    Dubas TC; Hrdina PD
    J Environ Pathol Toxicol; 1978; 2(2):471-84. PubMed ID: 739226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of lead on neurotransmission in rats.
    McIntosh MJ; Meredith PA; Moore MR; Goldberg A
    Xenobiotica; 1989 Jan; 19(1):101-13. PubMed ID: 2569255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ontogenic study on the effect of catecholamine receptor-stimulating agents on the turnover of noradrenaline and dopamine in the brain.
    Kellogg C; Wennerström G
    Brain Res; 1974 Oct; 79(3):451-64. PubMed ID: 4371328
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of immobilization stress-induced changes of ascorbic acid, noradrenaline, and dopamine metabolism in discrete brain areas of the rat.
    Desole MS; Miele M; Esposito G; Enrico P; De Natale G; Miele E
    Pharmacol Res; 1990; 22 Suppl 3():43-4. PubMed ID: 2097638
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: The effect of delta-1-tetrahydrocannabinol on the noradrenaline and dopamine content of the brain and heart of the rat.
    Graham JD; Lewis MJ; Williams J
    Br J Pharmacol; 1974 Nov; 52(3):446P. PubMed ID: 4458861
    [No Abstract]   [Full Text] [Related]  

  • 13. Responsiveness to d-amphetamine in lead-exposed rats as measured by steady state levels of catecholamines and locomotor activity.
    Rafales LS; Greenland RD; Zenick H; Goldsmith M; Michaelson IA
    Neurobehav Toxicol Teratol; 1981; 3(3):363-7. PubMed ID: 7290291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of some quinolizidine derivatives on the release of serotonin, noradrenaline, dopamine and acetylcholine from rat brain synaptosomes.
    Sparatore A; Marchi M; Maura G; Raiteri M
    Farmaco; 1989 Dec; 44(12):1205-16. PubMed ID: 2634407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of beta-phenethylamine on noradrenaline and dopamine turnover in rat brain.
    Jackson DM; Smythe DB
    J Pharm Pharmacol; 1974 Jun; 26(6):456-8. PubMed ID: 4154993
    [No Abstract]   [Full Text] [Related]  

  • 16. Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats.
    Kask A; Harro J; Tuomaine P; Rägo L; Männistö PT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):267-72. PubMed ID: 9050022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible significance of clozapine-induced increase in brain dopamine.
    Gianutsos G; Moore KE
    Res Commun Chem Pathol Pharmacol; 1977 May; 17(1):29-39. PubMed ID: 877404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra- and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats.
    Braestrup C; Nielsen M
    J Pharm Pharmacol; 1975 Jun; 27(6):413-9. PubMed ID: 237089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine?
    Zieve L; Olsen RL
    Gut; 1977 Sep; 18(9):688-91. PubMed ID: 342358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and neurochemical effects after combined perinatal treatment of rats with lead and disulfiram.
    Oskarsson A; Ljungberg T; Ståhle L; Tossman U; Ungerstedt U
    Neurobehav Toxicol Teratol; 1986; 8(5):591-9. PubMed ID: 3785522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.